Drug

Florzolotau F-18 clinical trials

Also written F-18 PMPBB3 and [18F]APN-1607.

studies test it: 9
open now: 3
in phase 3: 3
first study started: 2018

Keep track of what changes. Save the florzolotau F-18 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

9 studies that test it; most in 2019 (2)

Studies that test florzolotau F-18, by start year
Year	Studies
2018	1
2019	2
2021	2
2022	2
2026	2

By phase

A phase 1/2 study counts in both.

Early Phase 1: 2
Phase 1: 1
Phase 2: 3
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it.

Alzheimer Disease: 8
Supranuclear Palsy, Progressive: 1

Who runs them

Industry 4 · Other 5

Chang Gung Memorial Hospital (3) · JYAMS PET Research & Development Limited (2) · APRINOIA Therapeutics, LLC (1) · APRINOIA Therapeutics (1) · Invicro (1) · Nanjing First Hospital, Nanjing Medical University (1)

Often tested with

Tested in the same studies.

Florbetapir (1)

Studies

Open first, then newest update. How each study uses florzolotau F-18 is read from its arms, and is right about nine times in ten.

Testing it · 9

Codes

What other systems call florzolotau F-18 · ClinicalTrials.gg INT014970

UNII (FDA) 51M993JIQ4FLORZOLOTAU F-18One source FDA
NCI Thesaurus C190341Florzolotau F-18One source FDA

System	Code	Name there	Checked by
UNII (FDA)	51M993JIQ4	FLORZOLOTAU F-18	One source FDA
NCI Thesaurus	C190341	Florzolotau F-18	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.